{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T23:39:04Z","timestamp":1762472344549,"version":"build-2065373602"},"reference-count":44,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Angiol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the nearly 40 years that have elapsed since the first coronary stent implantation in man, there has been a multitude of trials regarding this procedure. Stents were designed to combat two major weaknesses of balloon angioplasty: a high restenosis rate (&gt;30%) and a 2 to 10% rate of abrupt closure. Early trials by some of the pioneers of the field suggested that stents, by scaffolding the artery, were indeed very successful in treating angioplasty-induced flow-limiting dissections. Findings of the BENESTENT-I (Belgian Netherlands stent trial) and STRESS (Stent Restenosis Study) demonstrated that stents reduced the restenosis rate to &lt;30%. Drug-eluting stents were developed to further reduce the restenosis rates. In the SIRIUS trial (Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery), when compared with a bare metal stent, a sirolimus-eluting stent reduced significantly the need for revascularization of target lesions. Concerns regarding late and very late stent thrombosis with these first-generation drug-eluting stents led to the development of second-generation stents. Multiple trials have demonstrated very low stent thrombosis rates (&lt;1%) with the latter stents. The promise of bioresorbable stents was dimmed by the findings of the ABSORB II trial (Bioresorbable Everolimus-Eluting Scaffold Versus a Metallic Everolimus-Eluting Stent). The findings of the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial suggests that the majority of patients with left main stem and three vessel coronary artery disease are better served by coronary artery bypass surgery rather than angioplasty with drug-eluting stents.<\/jats:p>","DOI":"10.1055\/a-2625-9999","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:00:32Z","timestamp":1750791632000},"page":"303-311","source":"Crossref","is-referenced-by-count":0,"title":["Coronary Stents: All Those Trials"],"prefix":"10.1055","volume":"34","author":[{"given":"Margaret Mary","family":"Glazier","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5239-3692","authenticated-orcid":false,"given":"James J.","family":"Glazier","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wayne State University, Detroit Medical Center, Detroit, Michigan"},{"name":"Department of Cardiology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"issue":"28","key":"ref1","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/eurheartj\/ehx339","article-title":"The stent story: how it all started\u2026","volume":"38","author":"U Sigwart","year":"2017","journal-title":"Eur Heart J"},{"issue":"28","key":"ref2","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/eurheartj\/ehx333","article-title":"40\u2009years on","volume":"38","author":"M Y Emmert","year":"2017","journal-title":"Eur Heart J"},{"key":"ref3","first-page":"235","volume-title":"Coronary stenting","author":"T Palmerini","year":"2018","edition":"8th ed."},{"key":"ref4","first-page":"187","volume-title":"Coronary stents","author":"F D Russo","year":"2018"},{"issue":"04","key":"ref5","first-page":"321","article-title":"[Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry]","volume":"6","author":"F Macaya-Ten","year":"2024","journal-title":"REC Interv Cardiol"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"U Sigwart","year":"1987","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.CIR.78.5.1121","article-title":"Emergency stenting for acute occlusion after coronary balloon angioplasty","volume":"78","author":"U Sigwart","year":"1988","journal-title":"Circulation"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199101033240103","article-title":"Angiographic follow-up after placement of a self-expanding coronary-artery stent","volume":"324","author":"P W Serruys","year":"1991","journal-title":"N Engl J Med"},{"issue":"05","key":"ref9","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/01.CIR.89.5.2026","article-title":"Intracoronary ultrasound observations during stent implantation","volume":"89","author":"S Nakamura","year":"1994","journal-title":"Circulation"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0735-1097(93)90827-N","article-title":"Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes","volume":"22","author":"B S George","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"08","key":"ref11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease","volume":"331","author":"P W Serruys","year":"1994","journal-title":"N Engl J Med"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease","volume":"331","author":"D L Fischman","year":"1994","journal-title":"N Engl J Med"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM199703203361201","article-title":"A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery","volume":"336","author":"F Versaci","year":"1997","journal-title":"N Engl J Med"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0735-1097(96)00349-X","article-title":"Stenting in chronic coronary occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty","volume":"28","author":"P A Sirnes","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/oxfordjournals.eurheartj.a061750","article-title":"Elective PTCA of totally occluded coronary arteries not associated with acute myocardial infarction; short-term and long-term results","volume":"6","author":"P W Serruys","year":"1985","journal-title":"Eur Heart J"},{"issue":"26","key":"ref16","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJM199912233412601","article-title":"Coronary angioplasty with or without stent implantation for acute myocardial infarction","volume":"341","author":"C L Grines","year":"1999","journal-title":"N Engl J Med"},{"issue":"23","key":"ref17","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial","volume":"103","author":"A Kastrati","year":"2001","journal-title":"Circulation"},{"issue":"08","key":"ref18","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0735-1097(03)00119-0","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial","volume":"41","author":"J Pache","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"ref20","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/hc4201.098056","article-title":"Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up","volume":"104","author":"J E Sousa","year":"2001","journal-title":"Circulation"},{"issue":"23","key":"ref21","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"M C Morice","year":"2002","journal-title":"N Engl J Med"},{"issue":"14","key":"ref22","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2007.06.029","article-title":"Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial","volume":"50","author":"M C Morice","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"ref23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"J W Moses","year":"2003","journal-title":"N Engl J Med"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"G W Stone","year":"2004","journal-title":"N Engl J Med"},{"issue":"14","key":"ref25","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","article-title":"A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease","volume":"50","author":"A Sch\u00f6mig","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"ref27","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jacc.2011.02.016","article-title":"A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial","volume":"57","author":"G W Stone","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"ref28","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jcin.2017.06.070","article-title":"Long-term safety and efficacy of platinum chromium everolimus-eluting stents in coronary artery disease: 5-year results from the PLATINUM trial","volume":"10","author":"C R Kelly","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2016.11.004","article-title":"5-year safety and efficacy of resolute zotarolimus-eluting stent: the RESOLUTE Global Clinical Trial Program","volume":"10","author":"R W Yeh","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"P W Serruys","year":"2010","journal-title":"N Engl J Med"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"e002372","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","article-title":"Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II randomized trial","volume":"8","author":"D J Kereiakes","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"09","key":"ref32","doi-asserted-by":"crossref","first-page":"e008152","DOI":"10.1161\/CIRCINTERVENTIONS.119.008152","article-title":"Clinical outcomes following implantation of thin-strut, bioabsorbable polymer-coated, everolimus-eluting SYNERGY stents","volume":"12","author":"D J Kereiakes","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial","volume":"388","author":"C von Birgelen","year":"2016","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"P W Serruys","year":"2016","journal-title":"Lancet"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.4244\/EIJ-D-23-00326","article-title":"A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study","volume":"19","author":"M Haude","year":"2023","journal-title":"EuroIntervention"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-0041-1723977","article-title":"Therapeutic options for left main, left main equivalent, and three-vessel disease","volume":"30","author":"J J Glazier","year":"2021","journal-title":"Int J Angiol"},{"issue":"15","key":"ref37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM200104123441502","article-title":"Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease","volume":"344","author":"P W Serruys","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"P W Serruys","year":"2009","journal-title":"N Engl J Med"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"F J Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"18","key":"ref40","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","article-title":"2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"64","author":"S D Fihn","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"F W Mohr","year":"2013","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(19)31997-X","article-title":"Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial","volume":"394","author":"D JFM Thuijs","year":"2019","journal-title":"Lancet"},{"issue":"25","key":"ref43","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"M E Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.jacc.2018.09.046","article-title":"SYNTAX score in patients with diabetes undergoing coronary revascularization in the FREEDOM trial","volume":"72","author":"R B Esper","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.jacc.2018.10.011","article-title":"Coronary bypass surgery for diabetes and multivessel disease: forget the SYNTAX","volume":"72","author":"P WM Fedak","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(19)32972-1","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial","volume":"395","author":"N R Holm","year":"2020","journal-title":"Lancet"}],"container-title":["International Journal of Angiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2625-9999.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T23:34:09Z","timestamp":1762472049000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2625-9999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":44,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2025,11,6]]},"published-print":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2625-9999","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1061-1711","1615-5939"],"issn-type":[{"type":"print","value":"1061-1711"},{"type":"electronic","value":"1615-5939"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}